Inventor · disambiguated record
Stephen G. Machatha
Also filed as: MACHATHA STEPHEN G · MACHATHA STEPHEN GITU
25 granted patents·20 pending applications·261 citations·filing 2008–2023
96Inventor score
Top patents by PatentIndex Score
45 records- 0197US8835407B2Pharmaceutical compositions comprising prasugrel and cyclodextrin derivatives and methods of making and using the sameMOSHER GEROLD L·Filed 2012·Granted Sep 16, 2014·117 cites·38 claims
- 0296US11197821B2Formulations for treatment of dry eye diseaseALDEYRA THERAPEUTICS INC·Filed 2019·Granted Dec 14, 2021·12 cites·24 claims
- 0394US11312692B1Polymorphic compounds and uses thereofALDEYRA THERAPEUTICS INC·Filed 2021·Granted Apr 26, 2022·11 cites·19 claims
- 0494US10426790B2Treatment of allergic eye conditions with cyclodextrinsALDEYRA THERAPEUTICS INC·Filed 2017·Granted Oct 1, 2019·20 cites·30 claims
- 0594US8236782B2Pharmaceutical compositions comprising prasugrel and cyclodextrin derivatives and methods of making and using the sameMOSHER GEROLD L·Filed 2010·Granted Aug 7, 2012·30 cites·34 claims
- 0693US11786518B2Ophthalmic formulations and uses thereofALDEYRA THERAPEUTICS INC·Filed 2020·Granted Oct 17, 2023·7 cites·23 claims
- 0793US10414732B2Polymorphic compounds and uses thereofALDEYRA THERAPEUTICS INC·Filed 2018·Granted Sep 17, 2019·20 cites·15 claims
- 0892US11911385B1Methotrexate treatment methodsALDEYRA THERAPEUTICS INC·Filed 2022·Granted Feb 27, 2024·1 cites·20 claims
- 0991US8343995B2Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of useCYDEX PHARMACEUTICALS INC·Filed 2008·Granted Jan 1, 2013·17 cites·46 claims
- 1087US9399067B2Pharmaceutical compositions comprising prasugrel and cyclodextrin derivatives and methods of making and using the sameCYDEX PHARMACEUTICALS INC·Filed 2014·Granted Jul 26, 2016·7 cites·22 claims
- 1186US12064516B2Pharmaceutical formulations and uses thereofALDEYRA THERAPEUTICS INC·Filed 2021·Granted Aug 20, 2024·1 cites·10 claims
- 1284US10940128B2Injectable melphalan compositions comprising a cyclodextrin derivative and methods of making and using the sameCYDEX PHARMACEUTICALS INC·Filed 2013·Granted Mar 9, 2021·2 cites·14 claims
- 1383US8853236B2Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of useCYDEX PHARMACEUTICALS INC·Filed 2012·Granted Oct 7, 2014·5 cites·17 claims
- 1482US9125945B2Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of useCYDEX PHARMACEUTICALS INC·Filed 2014·Granted Sep 8, 2015·4 cites·10 claims
- 1582US2024139137A1Injectable Nitrogen Mustard Compositions Comprising a Cyclodextrin Derivative and Methods of Making and Using the SameCYDEX PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1682US2024156766A1Injectable melphalan compositions comprising a cyclodextrin derivative and methods of making and using the sameCYDEX PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1781US12029735B2Polymorphic compounds and uses thereofALDEYRA THERAPEUTICS INC·Filed 2021·Granted Jul 9, 2024·1 cites·21 claims
- 1881US10034947B2Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of useCYDEX PHARMACEUTICALS INC·Filed 2017·Granted Jul 31, 2018·2 cites·20 claims
- 1980US12005061B2Ophthalmic formulations of methotrexateALDEYRA THERAPEUTICS INC·Filed 2022·Granted Jun 11, 2024·0 cites·27 claims
- 2079US12098132B2Process for preparation of aldehyde scavenger and intermediatesALDEYRA THERAPEUTICS INC·Filed 2020·Granted Sep 24, 2024·1 cites·9 claims
- 2179US12006298B2Polymorphic compounds and uses thereofALDEYRA THERAPEUTICS INC·Filed 2019·Granted Jun 11, 2024·1 cites·20 claims
- 2278US12005060B2Ophthalmic formulations of methotrexateALDEYRA THERAPEUTICS INC·Filed 2022·Granted Jun 11, 2024·0 cites·16 claims
- 2378US10864183B2Injectable nitrogen mustard compositions comprising a cyclodextrin derivative and methods of making and using the sameCYDEX PHARMACEUTICALS INC·Filed 2019·Granted Dec 15, 2020·0 cites·10 claims
- 2475US10111863B2Pharmaceutical compositions comprising prasugrel and cyclodextrin derivatives and methods of making and using the sameCYDEX PHARMACEUTICALS INC·Filed 2016·Granted Oct 30, 2018·1 cites·20 claims
- 2574US2024197740A1Methotrexate treatment methodsALDEYRA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2673US9623045B2Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of useCYDEX PHARMACEUTICALS INC·Filed 2015·Granted Apr 18, 2017·1 cites·16 claims
- 2771US11020363B2Injectable nitrogen mustard compositions comprising a cyclodextrin derivative and methods of making and using the sameCYDEX PHARMACEUTICALS INC·Filed 2014·Granted Jun 1, 2021·0 cites·7 claims
- 2871US2021379000A1Injectable melphalan compositions comprising a cyclodextrin derivative and methods of making and using the sameCYDEX PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 2970US2024139173A1Ophthalmic formulations and uses thereofALDEYRA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3070US2021046033A1Injectable Nitrogen Mustard Compositions Comprising a Cyclodextrin Derivative and Methods of Making and Using the SameCYDEX PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 3166US10512697B2Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of useCYDEX PHARMACEUTICALS INC·Filed 2018·Granted Dec 24, 2019·0 cites·14 claims
- 3266US2022133629A1Formulations for treatment of dry eye diseaseALDEYRA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3365US2022370460A1Ophthalmic formulations of methotrexateALDEYRA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3463US2025228840A1Methods of treating sjögren-larssen syndromeALDEYRA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3560US2022211691A1Treatment of dry eye diseaseALDEYRA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3658US2024383870A1Heterocyclic aldehyde trapping compounds and uses thereofALDEYRA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3755US2022133697A1Injectable formulationsALDEYRA THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 3854US2023131929A1Quinoline compounds for treating respiratory disorders and viral infectionsALDEYRA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3954US2023228744A1Dry eye disease biomarkers and their use for treatmentALDEYRA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4051US2010311838A1Injectable Melphalan Compositions Comprising a Cyclodextrin Derivative and Methods of Making and Using the SamePIPKIN JAMES D·Filed 2010·Application pending·0 cites
- 4151US2020038392A1Topical compositions and methods of preparation and useALDEYRA THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 4251US2020062712A1Aldehyde trapping compounds and uses thereofALDEYRA THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 4347US2023149383A1Quinoline compounds for treating lung, liver, and kidney diseases, disorders, or conditionsALDEYRA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4447US2018050989A1Aldehyde trapping compounds and uses thereofALDEYRA THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 4546US2021317385A1Contact lens solutions and kitsALDEYRA THERAPEUTICS INC·Filed 2019·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →